Evidence map›Paper›PMID 36353572›Full record

ArticleFrontiers in psychiatry2022

Mapping network connectivity between internet addiction and residual depressive symptoms in patients with depression.

Hong Cai, Wei Bai, Yan Yue, Ling Zhang, Wen-Fang Mi, Yu-Chen Li, Huan-Zhong Liu, Xiangdong Du, Zhen-Tao Zeng, Chang-Mou Lu and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 3 countries.

Hong CaiUnit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao, Macao SAR, China.
Wei BaiUnit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao, Macao SAR, China.
Yan YueGuangji Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, China.
Ling ZhangNanning Fifth People's Hospital, Nanning, Guangxi, China.
Wen-Fang MiDepartment of Psychiatry, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Yu-Chen LiDepartment of Psychiatry, Xiamen Xianyue Hospital, Xiamen, Fujian Province, China.
Huan-Zhong LiuDepartment of Psychiatry, Chaohu Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Xiangdong DuGuangji Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, China.
Zhen-Tao ZengNanning Fifth People's Hospital, Nanning, Guangxi, China.
Chang-Mou LuNanning Fifth People's Hospital, Nanning, Guangxi, China.
Lan ZhangDepartment of Psychiatry, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Ke-Xin FengSchool of Public Health, Lanzhou University, Lanzhou, Gansu Province, China.
Yan-Hong DingDepartment of Psychiatry, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Juan-Juan YangDepartment of Psychiatry, Chaohu Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Todd JacksonDepartment of Psychology, University of Macau, Macao, Macao SAR, China.
Teris CheungSchool of Nursing, Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.
Feng-Rong AnThe National Clinical Research Center for Mental Disorders and Beijing Key Laboratory of Mental Disorders, Beijing Anding Hospital and the Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
Yu-Tao XiangUnit of Psychiatry, Department of Public Health and Medicinal Administration, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao, Macao SAR, China.
University of Macau · MOLanzhou University Second Hospital · CNThe Second Nanning People's Hospital · CNAnhui Medical University · CNSoochow University · CNCapital Medical University · CNHong Kong Polytechnic University · HKLanzhou University · CNTianjin haihe hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Depression often triggers addictive behaviors such as Internet addiction. In this network analysis study, we assessed the association between Internet addiction and residual depressive symptoms in patients suffering from clinically stable recurrent depressive disorder (depression hereafter). Materials and methods: In total, 1,267 depressed patients were included. Internet addiction and residual depressive symptoms were measured using the Internet Addiction Test (IAT) and the two-item Patient Health Questionnaire (PHQ-2), respectively. Central symptoms and bridge symptoms were identified via centrality indices. Network stability was examined using the case-dropping procedure. Results: The prevalence of IA within this sample was 27.2% (95% CI: 24.7-29.6%) based on the IAT cutoff of 50. IAT15 ("Preoccupation with the Internet"), IAT13 ("Snap or act annoyed if bothered without being online") and IAT2 ("Neglect chores to spend more time online") were the most central nodes in the network model. Additionally, bridge symptoms included the node PHQ1 ("Anhedonia"), followed by PHQ2 ("Sad mood") and IAT3 ("Prefer the excitement online to the time with others"). There was no gender difference in the network structure. Conclusion: Both key central and bridge symptoms found in the network analysis could be potentially targeted in prevention and treatment for depressed patients with comorbid Internet addiction and residual depressive symptoms.

Indexed as

central symptomsinternet addictionmajor depressive disordernetwork analysisresidential depressive symptoms

Identifiers

PMID36353572
PMCPMC9638086
OpenAlexW4307156384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.